Sequential Vaccination With Heterologous Acinetobacter baumannii Strains Induces Broadly Reactive Antibody Responses

Antibody therapy may be an alternative treatment option for infections caused by the multi-drug resistant (MDR) bacterium Acinetobacter baumannii. As A. baumannii has multiple capsular serotypes, a universal antibody therapy would need to target conserved protein antigens rather than the capsular po...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gathoni Kamuyu, Yat Suen Cheng, Sam Willcocks, Chidchamai Kewcharoenwong, Pattarachai Kiratisin, Peter W. Taylor, Brendan W. Wren, Ganjana Lertmemongkolchai, Richard A. Stabler, Jeremy Brown
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-07-01
Edice:	Frontiers in Immunology
Témata:	A. baumannii antibodies growth inhibition neutrophils heterologous protection
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.705533/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!